GlassScriptPhysician profile
Lindsey A Andreoli
NPI 1821498023
$2,087.87
in general payments reported to CMS, 2019-2025
24 companies · $799 in 2025
The $799 reported for 2025 was more than what 81% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $170 · 2023: $956 · 2024: $162 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,917.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $416.09 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $286.72 | 2022-2025 | Airsupra, Nexium, Farxiga |
| Pfizer INC. | $207.00 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $184.04 | 2022-2025 | Rexulti |
| Novo Nordisk INC | $121.97 | 2022-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $121.96 | 2022-2025 | Mounjaro, Zepbound |
| Amgen INC. | $118.68 | 2023-2025 | Repatha, Repatha, Otezla |
| Exact Sciences Corporation | $95.45 | 2023 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $82.74 | 2023 | Quviviq |
| Esperion Therapeutics, INC. | $79.49 | 2022-2023 | Nexletol |
| Glaxosmithkline, LLC. | $78.61 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Edwards Lifesciences Corporation | $48.34 | 2022-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Hologic Sales and Service, LLC | $45.19 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Biohaven Pharmaceutical Holding Company LTD. | $29.66 | 2022 | |
| Viiv Healthcare Company | $23.41 | 2025 | Apretude |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $23.10 | 2025 | Fluad, Flucelvax |
| Bayer Healthcare Pharmaceuticals INC. | $18.13 | 2025 | |
| Novartis Pharmaceuticals Corporation | $17.25 | 2023 | |
| Nevro Corp. | $17.06 | 2024 | Senza |
| Janssen Pharmaceuticals, INC | $15.81 | 2023 | Xarelto |
| Acella Pharmaceuticals, LLC | $15.05 | 2025 | NP Thyroid 60 |
| Indivior INC. | $14.36 | 2024 | Sublocade |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.98 | 2023 | Trulance, Xifaxan |
| Merck Sharp & Dohme LLC | $13.78 | 2023 | Rotateq, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Andreoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.